Shuttle–Cargo Fusion Molecules of Transport Peptides and the hD2/3 Receptor Antagonist Fallypride: A Feasible Approach To Preserve Ligand–Receptor Binding?
To determine if the conjugation of a small receptor ligand to a peptidic carrier to potentially facilitate transport across the blood–brain barrier (BBB) by “molecular Trojan horse” transcytosis is feasible, we synthesized several transport peptide–fallypride fusion